Filing Details

Accession Number:
0001171843-17-004960
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-10 19:58:13
Reporting Period:
2017-08-08
Filing Date:
2017-08-10
Accepted Time:
2017-08-10 19:58:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1582313 Xenon Pharmaceuticals Inc. XENE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1283535 Gary Patou C/O Xenon Pharmaceuticals Inc
200 - 3650 Gilmore Way
Burnaby A1 V5G 4W8
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-08 5,000 $3.00 5,000 No 4 P Indirect See note
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See note
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 12,028 Direct
Footnotes
  1. By Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou